SCHEMBL7157484

SCHEMBL7157484

C=CC(=O)C1(O)CC(=O)NC1=O

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
DDB1 Q16531 1/20 0.30
CRBN Q96SW2 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9488706 0.68 TSHR (0.30) TSHRNPSR1
SCHEMBL3189534 0.65 TSHR (0.36) TSHRNPSR1
Ethylene SCHEMBL4351883 0.64 TSHR (0.38) TSHRNPSR1CRBNCYP19A1
SCHEMBL20581839 0.64 TSHR (0.36) TSHRNPSR1CYP19A1
SCHEMBL3255645 0.63
Bicarbonate SCHEMBL9560500 0.63 TSHR (0.37) TSHRNPSR1DDB1CRBNCYP19A1
SCHEMBL27992207 0.63 TSHR (0.37) TSHRNPSR1CYP19A1
Oxalic Acid SCHEMBL9221357 0.61 TSHR (0.35) TSHRNPSR1DDB1CRBN
SCHEMBL18921794 0.61 HDAC1 (0.31) TSHRNPSR1
SCHEMBL14992026 0.61 DDB1 (0.32) TSHRNPSR1DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6538089-B1 Crosslinked terpolymer comprising monomers of N-isopropylacrylamide, N-acryloyloxysuccinimide, and styrene; drug delivery FORSKARPATENT I SYD AB (SE) 2003-03-25 US claimed
WO-2000046262-A1 GELS WITH A SHAPE MEMORY FORSKARPATENT I SYD AB (SE) 2000-08-10 WO claimed
US-6538089-B1 Crosslinked terpolymer comprising monomers of N-isopropylacrylamide, N-acryloyloxysuccinimide, and styrene; drug delivery FORSKARPATENT I SYD AB (SE) 2003-03-25 US disclosed
WO-2000046262-A1 GELS WITH A SHAPE MEMORY FORSKARPATENT I SYD AB (SE) 2000-08-10 WO disclosed